Greene John bought CRSP
June 5, 2026 · Form 4 insider transaction
Greene John bought 13,000 shares of CRISPR Therapeutics AG at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
13,000
Price
$0.00
Total value
N/A
InsiderGreene John
RoleDirector
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJune 5, 2026
Filing dateJune 9, 2026
Shares owned after13,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Subject to continued service to the Company or any of its subsidiaries, the options will vest and become exercisable in 12 equal monthly installments on the final day of each succeeding calendar month occurring after the grant date provided that the first installment vests on June 30, 2026 and the last installment vests on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2027 Annual Meeting.